| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/09/2009 | WO2009043441A1 D-ala-gln-octadecyl ester as a therapeutic agent |
| 04/09/2009 | WO2009043440A2 Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agent |
| 04/09/2009 | WO2009043439A2 Use of retrocyclin- 1 as a therapeutic agent for the treatment of hcmv infections |
| 04/09/2009 | WO2009043437A2 Use of t140 and optionally retrocyclin-1 as therapeutic agents for the treatment of m. tuberculosis infections |
| 04/09/2009 | WO2009043436A2 Use of af12198 as a therapeutic agent |
| 04/09/2009 | WO2009043354A2 Combination treatment for the treatment of hepatitis c virus infection |
| 04/09/2009 | WO2009043307A1 Medicine composition containing abafungin |
| 04/09/2009 | WO2009043176A1 Herbal compositions and methods for treating hepatic disorders |
| 04/09/2009 | WO2009043165A1 Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof |
| 04/09/2009 | WO2009043155A2 Distinct hiv-1 gag and env epitopes of hla alleles associated with differential susceptibility to hiv-1 infection |
| 04/09/2009 | WO2009043134A1 Mouthwash and method of using same for the treatment of mucositis or stomatitis |
| 04/09/2009 | WO2009043128A1 Use of protease inhibitors isolated from bauhinia sp. for the treatment of microbial infections and pharmaceutical composition |
| 04/09/2009 | WO2009013171A3 Heterocyclic antiviral compounds |
| 04/09/2009 | WO2009012785A3 Complexes of an emulgator and a fatty acid |
| 04/09/2009 | WO2009005551A3 Transcription factor modulating compounds and methods of use thereof |
| 04/09/2009 | WO2009003595A3 Macrolactone derivatives |
| 04/09/2009 | WO2008138943A3 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies |
| 04/09/2009 | WO2008137126A3 Combination therapy for the treatment of hcv infection |
| 04/09/2009 | WO2008079464A3 Stable powder formulations of alum-adsorbed vaccines |
| 04/09/2009 | WO2008058285A3 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors |
| 04/09/2009 | US20090093622 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis |
| 04/09/2009 | US20090093533 Compounds and methods for inhibiting hepatitis c viral replication |
| 04/09/2009 | US20090093507 Cdk inhibitors containing a zinc binding moiety |
| 04/09/2009 | US20090093501 Heterocyclic antiviral compounds |
| 04/09/2009 | US20090093468 Peptide Deformylase Inhibitors |
| 04/09/2009 | US20090093455 Quinolone analogs and methods related thereto |
| 04/09/2009 | US20090093454 Chemical Compounds |
| 04/09/2009 | US20090093449 dissolving azithromycin in an aqueous solution comprising a strong acid, and adding solution to sterilized solution comprising a strong base, wherein strong acid has a pKa less than -1.74; pulmonary infection, nasopharyngeal infection, otic infection, ocular infection, dermal or vaginal infections |
| 04/09/2009 | US20090093433 SENSE mRNA THERAPY |
| 04/09/2009 | US20090093428 Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis |
| 04/09/2009 | US20090093423 Such as 1-{[(2S,3S,5R)-2-Carboxy-3-methyl-4,4,7-trioxo-4-thia-1-azabicyclo[3.2.0]hept-3-yl]methyl}-3-methyl-1H-1,2,3-triazol-3-ium; beta-lactamase inhibitors |
| 04/09/2009 | US20090093420 Processes for the preparation of azithromycin |
| 04/09/2009 | US20090093409 Neuroprotective synergy of erythropoietin and insulin-like growth factors |
| 04/09/2009 | US20090093398 Use of Fibroblast Growth Factor Fragments |
| 04/09/2009 | US20090092684 Small molecule antagonists of bcl-2 family proteins |
| 04/09/2009 | US20090092659 containing protonated/acidified nucleic acids that are bactericidal; wound sealant, surgical drape , skin substitute |
| 04/09/2009 | US20090092648 Antimicrobial polymer compositions and the use thereof |
| 04/09/2009 | US20090092645 Radiation Method for Fabrication of Nano-sized Compound Antibacterial Fabric Textile |
| 04/09/2009 | US20090092641 Uses of natural immunobiotic extract |
| 04/09/2009 | US20090092636 Multivalent pcv2 immunogenic compositions and methods of producing such compositions |
| 04/09/2009 | US20090092635 Heterologous prime-boost immunization regimen |
| 04/09/2009 | US20090092634 Chicken Virus Vaccine and Diagnostic |
| 04/09/2009 | US20090092633 Polyamino acid for use as adjuvant |
| 04/09/2009 | US20090092632 Methods for preparing complex multivalent immunogenic conjugates |
| 04/09/2009 | US20090092624 Antiinfective Flavononol Compounds and Methods of Use Thereof |
| 04/09/2009 | US20090092622 Molecules, compositions, methods and kits for applications associated with flaviviruses |
| 04/09/2009 | US20090092620 Flu virus hemagglutinin specific monoclonal antibodies |
| 04/09/2009 | US20090092611 Antibodies that bind both bcma and taci |
| 04/09/2009 | US20090092609 Monoclonal antibodies to respiratory syncytial virus and uses therefor |
| 04/09/2009 | US20090092606 Antibacterial treatments |
| 04/09/2009 | US20090092594 Mammalian genes involved in viral infection and tumor suppression |
| 04/09/2009 | US20090092592 Methionyl tRNA Synthetase Polynucleotides |
| 04/09/2009 | US20090092581 Interferons of rhesus and cynomolgus origin and uses thereof |
| 04/09/2009 | US20090092545 Antibodies that bind both bcma and taci |
| 04/09/2009 | DE19543553B4 VP-Antigene des JC-Virus VP-antigens of the JC virus |
| 04/09/2009 | DE10223934B4 Verwendung eines Desinfektionsmittels zur Inaktivierung von Hepatitis B-Virus Use of a disinfectant for the inactivation of hepatitis B virus |
| 04/09/2009 | DE102007048080A1 Biomedizinische Schaumartikel Biomedical foam article |
| 04/09/2009 | CA2710406A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2701778A1 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 04/09/2009 | CA2701768A1 Thiophene-2-carboxamide derivatives as modulators of ccr9 receptor |
| 04/09/2009 | CA2701719A1 Dry powders of cellular material |
| 04/09/2009 | CA2701630A1 Quinolone analogs and methods related thereto |
| 04/09/2009 | CA2701618A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation |
| 04/09/2009 | CA2701583A1 Mouthwash and method of using same for the treatment of mucositis or stomatitis |
| 04/09/2009 | CA2701406A1 Benzoxazinone derivative |
| 04/09/2009 | CA2701356A1 Potent combinations of zidovudine and drugs that select for the k65r mutation in the hiv polymerase |
| 04/09/2009 | CA2701274A1 Lipopeptides for delivery of nucleic acids |
| 04/09/2009 | CA2701190A1 Herbal compositions and methods for treating hepatic disorders |
| 04/09/2009 | CA2701118A1 Inhaled aztreonam lysine for the treatment of deficits in health-related quality-of-life in lung diseases |
| 04/09/2009 | CA2701031A1 Oral compositions containing botanical extracts |
| 04/09/2009 | CA2701025A1 Anti-bacterial pyrocatechols and related methods |
| 04/09/2009 | CA2700857A1 Hdac inhibitors |
| 04/09/2009 | CA2700828A1 Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof |
| 04/09/2009 | CA2700530A1 Antifungal agents |
| 04/09/2009 | CA2699264A1 Substance p and thyrotropin releasing hormone for therapeutic applications |
| 04/09/2009 | CA2699260A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2699255A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2699114A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2699113A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2699109A1 Use of urocortin and corticotropin-releasing factor as therapeutic agents |
| 04/09/2009 | CA2699107A1 Use of a platelet fibrinogen receptor hexapeptide antagonist and alpha-endorphin as therapeutic agents |
| 04/09/2009 | CA2699105A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2699104A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2699078A1 Use of grf-1 (1-29 ) and corticotropin-releasing factor as therapeutic agents |
| 04/09/2009 | CA2699074A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2699067A1 Use of rfrp, alone or in combination with neurokinin-b, as a therapeutic agent |
| 04/09/2009 | CA2698690A1 Thyrotropin releasing hormone for therapeutic applications |
| 04/09/2009 | CA2698688A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2698687A1 Use of a peptide as a therapeutic agent |
| 04/08/2009 | EP2045329A1 Flagellin mutant vaccine |
| 04/08/2009 | EP2045324A1 Method for production of n36-binding peptide |
| 04/08/2009 | EP2045248A1 Method for preventing coloration of catechins and dentifrice composition |
| 04/08/2009 | EP2045243A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof |
| 04/08/2009 | EP2045242A1 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 04/08/2009 | EP2045237A1 Pyrrole compounds as inhibitors of mycrobacteria, synthesis thereof and intermediates thereto |
| 04/08/2009 | EP2044954A1 Treatment of fungal infections |
| 04/08/2009 | EP2044953A1 Viral antigens |
| 04/08/2009 | EP2044950A2 Attenuated VIF DNA immunization cassettes for genetic vaccines |
| 04/08/2009 | EP2044101A2 Aminothiazole derivatives and their uses as antibacterial agents |
| 04/08/2009 | EP2044085A2 Penem prodrugs |